Semen evaluation in heroin and methadone addicts

Area of Science:

• Reproductive Medicine
• Addiction Medicine
• Andrology

Background:

• Opioid addiction, including heroin and methadone use, is a significant public health concern.
• Male infertility is a complex issue with various contributing factors.
• Previous research suggests potential links between substance abuse and reproductive health.

Purpose of the Study:

• To investigate the prevalence and types of semen abnormalities in individuals dependent on heroin and/or methadone.
• To explore potential correlations between specific drug use patterns and semen quality.
• To assess the impact of methadone-only use on male reproductive parameters.

Main Methods:

• A cohort of 32 male addicts was studied, categorized into four groups based on drug use: heroin-dependent, chronic methadone/heroin users, occasional methadone/heroin users, and methadone-only users.
• Semen analysis was performed to evaluate parameters including sperm motility, morphology (teratozoospermia), and count (oligozoospermia).

Main Results:

• A high prevalence of abnormal semen was observed: 93% in heroin addicts and 65% in methadone users.
• Reduced sperm motility was the most common abnormality (78%), followed by teratozoospermia (28%) and oligozoospermia (16%).
• Patients using methadone exclusively did not exhibit teratozoospermia or oligozoospermia.

Conclusions:

• Heroin and methadone use are associated with significant semen pathology, primarily affecting sperm motility.
• The observed semen abnormalities may be linked to decreased testosterone production and subsequent hypofunction of the reproductive tract.
• Methadone-only use appears to have a less detrimental effect on sperm morphology and count compared to combined or heroin use.